Home > Insider Trading > Filing (0001104659-10-015701)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339455	Somaxon Pharmaceuticals Inc.	SOMX	Pharmaceutical Preparations (2834)	200161599

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1094330	D Howard Palefsky	2700 Sana Hill Road Menlo Park CA 94025	No	No	Yes	No
1256646	P L Sbic Iii Partners Equity Montreux		No	No	Yes	No
1277894	Montreux Equity Partners Ii Sbic Lp	2500 Sand Hill Road Suite 215 Menlo Park CA 94025	No	No	Yes	No
1280248	Montreux Equity Management Ii Sbic Llc	2500 Sand Hill Road 215 Menlo Park CA 94025	No	No	Yes	No
1280249	Iii K Daniel Turner	2500 Sand Hill Road 215 Menlo Park CA 94025	No	No	Yes	No
1397992	Sbic Iii Managment Equity Montreux	3000 Sand Hill Road Building 1, Suite 260 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-18	1,500,000	$6.38	695,505	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale price reported in this Form 4 was between the range of $6.78 per share and $6.25 per share. Full information regarding the number of shares sold at each separate price will be provided to the Commission staff upon request.
The reported securities are owned directly by Montreux Equity Partners II SBIC, L.P., ("MEP II") and Montreux Equity Partners III SBIC, L.P, ("MEP III") and may be deemed to be beneficially owned indirectly by Montreux Equity Management II SBIC, LLC ("MEM II"), as general partner of MEP II and Montreux Equity Management III SBIC, LLC ("MEM III"), as general partner of MEP III. Each of MEM II and MEM III disclaims any beneficial ownership of the reported securities except to the extent of any pecuniary interest therein. The managing members of MEM II and MEM III are Howard D. Palefsky and Daniel K. Turner III ("Managing Members"). Each of the Managing Members disclaims any beneficial ownership of the reported securities except to the extent of any pecuniary interest therein.